Moderna公司宣布,针对新冠病毒变异株LP.8.1的加拿大生产疫苗剂量预计将在今年秋季推出供应。这批疫苗专门针对LP.8.1变异株进行了优化设计,将在加拿大本土生产制造。
Moderna公司宣布,针对新冠病毒变异株LP.8.1的加拿大生产疫苗剂量预计将在今年秋季推出供应。这批疫苗专门针对LP.8.1变异株进行了优化设计,将在加拿大本土生产制造。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.